Tilray Inc (NASDAQ:TLRY - Get Free Report) CFO Carl A. Merton bought 26,000 shares of the company's stock in a transaction on Friday, November 15th. The shares were acquired at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the acquisition, the chief financial officer now owns 26,000 shares in the company, valued at $35,360. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Tilray Stock Down 2.2 %
Shares of NASDAQ TLRY traded down $0.03 during trading hours on Monday, hitting $1.32. 29,124,652 shares of the stock were exchanged, compared to its average volume of 25,532,219. Tilray Inc has a 12 month low of $1.30 and a 12 month high of $2.97. The firm has a fifty day moving average price of $1.65 and a 200-day moving average price of $1.76. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.19 billion, a PE ratio of -4.87 and a beta of 2.14.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts' consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company had revenue of $200.00 million during the quarter, compared to analysts' expectations of $218.70 million. During the same period last year, the business posted ($0.10) earnings per share. The firm's revenue was up 13.0% compared to the same quarter last year. On average, sell-side analysts expect that Tilray Inc will post -0.14 EPS for the current year.
Institutional Investors Weigh In On Tilray
A number of large investors have recently made changes to their positions in the stock. Prospect Financial Services LLC acquired a new position in shares of Tilray in the second quarter valued at about $26,000. Ferguson Wellman Capital Management Inc. purchased a new position in Tilray during the 3rd quarter worth approximately $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in Tilray during the 2nd quarter valued at approximately $29,000. Jeppson Wealth Management LLC purchased a new stake in shares of Tilray in the 2nd quarter valued at $33,000. Finally, Vanguard Capital Wealth Advisors acquired a new stake in shares of Tilray in the second quarter worth $34,000. 9.35% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Roth Mkm dropped their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a research note on Friday, October 11th.
Get Our Latest Report on TLRY
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
